A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC

被引：0

作者：

Spigel, David ^{[1
]}

Luft, Alexander ^{[2
]}

Vynnychenko, Ihor ^{[3
]}

Fadeeva, Natalia ^{[4
]}

Mark, Zsuzsanna ^{[5
]}

Ponce, Santiago ^{[6
]}

Matrosova, Marina ^{[7
]}

Goldschmidt, Jerome ^{[8
]}

Szima, Barna ^{[9
]}

Saleh, Mansoor ^{[10
]}

Lackner, Mark ^{[11
]}

Gendreau, Steve ^{[11
]}

Bassett, Katia ^{[11
]}

Spoerke, Jill ^{[11
]}

Koeppen, Hartmut ^{[11
]}

Gilbert, Houston ^{[11
]}

Jin, Huan ^{[11
]}

Shankar, Geetha ^{[11
]}

Lin, Wei ^{[11
]}

Denis, Fabrice ^{[12
]}

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] Leningrad Reg Clin Hosp, St Petersburg, Russia

[3] Sumy State Univ, Sumy, Ukraine

[4] Chelyabinsk Reg Clin Oncol Dispensary, Chelyabinsk, Russia

[5] Tudogyogyintezet Torokbalint, Torokbalint, Hungary

[6] Hosp Univ 12 Octubre, Madrid, Spain

[7] N Novgorod Reg Oncol Dispensary, Novgorod, Russia

[8] US Oncol Network, Marion, VA USA

[9] Markusovszky Hosp, Szombathely, Hungary

[10] Georgia Canc Specialists, Marietta, GA USA

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] Victor Hugo Clin, Jean Bernard Ctr, Le Mans, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

squamous; metastatic; P13K; Placebo-controlled;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI30.13

引用

页码：S375 / S375

页数：1

共 50 条

[1] A Multicenter Phase II Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Kim, Hae Su
Lim, Tae Kyu
Nam, Seung-Hyun
Choi, Yoon Hee
Won, Young-Woong
Kim, Hoon-Gu
Sun, Jong-Mu
Kwon, Jung Hye
Kim, Ki-Hyang
Jang, Joung Soon
Kang, Jin Hyoung
Kim, Bong-Seog
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1233 - S1234
[2] Phase II trial of personalized chemotherapy in stage IV NSCLC: Clinical application of functional profiling in first-line therapy
Nagourney, R. A.
Blitzer, J. B.
Deo, E. A.
Nandan, R.
Shuman, R.
Ascluto, T.
McConnell, D.
Paulsen, M.
Evans, S. S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[3] A Phase I/II Trial of IO102 and Pembrolizumab With/Without Chemotherapy as First-line Treatment of Metastatic NSCLC
Provencio, M.
Spicer, J.
Garrido, P.
Trigo Perez, J. M.
Viteri, S.
Bosch-Barrera, J.
Insa, A.
Felip, E.
De Castro Carpeno, J.
Coart, E.
Schmidt, E.
Christiansen, A.
Andersen, M. Hald
Zocca, M.
Ehrnrooth, E.
Paz-Aras, L.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S643 - S643
[4] First-line immune-chemotherapy combination for squamous NSCLC is already a reality
Hendriks, Lizza E. L.
Menis, Jessica
Remon, Jordi
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 819 - 823
[5] Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
Saltos, Andreas Nicholas
Tanvetyanon, Tawee
Creelan, Ben C.
Shafique, Michael Rahman
Antonia, Scott Joseph
Haura, Eric B.
Zheng, Hong
Barlow, Margaret
Saller, James
Castellano-Fornelli, Anna
Richards, Antoine
Thapa, Ram
Boyle, Theresa A.
Chen, Dung-Tsa
Beg, Amer A.
Gray, Jhanelle Elaine
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients
Bécouarn, Y
Ychou, M
Ducreux, M
Borel, C
Bertheault-Cvitkovic, F
Seitz, JF
Nasca, S
Nguyen, TD
Paillot, B
Raoul, JL
Duffour, J
Fandi, A
Dupont-André, G
Rougier, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2739 - 2744
[7] A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer
Xiong, Jian Ping
Zhang, Ling
Zhong, Lu Xing
Qiu, Feng
Xu, Jun
Tao, Qing Song
Xiang, Xiao Jun
Yu, Feng
Tang, Xiao Mei
[J]. ANTI-CANCER DRUGS, 2007, 18 (09) : 1103 - 1107
[8] Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
Andric, Zoran
Galffy, Gabriella
Dols, Manuel Cobo
Szima, Barna
Stojanovic, Goran
Petrovic, Marina
Felip, Enriqueta
Baz, David Vicente
Aix, Santiago Ponce
Juan-Vidal, Oscar
Szalai, Zsuzsanna
Losonczy, Gyorgy
Blanco, Antonio Calles
Bernabe, Reyes
Ledo, Gema Garcia
Hernandez, Andres Aguilar
Duecker, Klaus
Zhou, Dongli
Schroeder, Andreas
Guezel, Guelseren
Ciardiello, Fortunato
[J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
[9] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
Ghosn, M
Kattan, J
Farhat, F
Younes, F
Gasmi, J
[J]. ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
[10] Phase II trial of target-guided personalized chemotherapy in first-line metastatic colorectal
Cubillo, Antonio
Rodriguez-Pascual, Jesus
Lopez-Rios, Fernando
Plaza, Carlos
Garcia, Elena
Alvarez-Gallego, Rafael
De Vicente, Emilio
Quijano, Yolanda
Hernando, Ovidio
Rubio, Carmen
Hidalgo, Manuel
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →